PQR620
PQR620 is a novel, selective, orally bioavailable and brain penetrant dual TORC1/2 inhibitor. PQR620 has anti-tumor activity across 56 lymphoma models with a median IC50 of 250 nM after 72 h of exposure.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | S8784 |
| Sku # | S8784-2mg |
| Pricing | 2mg, $217.00 |